NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE
Sue Bacon/LinkedIn
Sep 29, 2025, 05:06

Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE

Sue Bacon, VTE specialist – Quality Improvement at North Bristol NHS Trust, reposted from Firstkind Ltd on LinkedIn:

”It’s so important to ask this question – hospital acquired DVT and PE is not uncommon, and sometimes linked to lack of an assessment of your individual risk, but also, sadly, because patients do not understand enough and refuse the medication/devices.

Please, please ask.”

Firstkind Ltd shared on LinkedIn:

”Did you know?

More people die each year in the UK from hospital-acquired venous thromboembolism (VTE) than from breast cancer, AIDS, and traffic accidents combined.

VTE is a leading cause of preventable death in hospitals — yet it’s often overlooked.

The good news? Most cases are entirely preventable with timely risk assessments and appropriate treatment.

Innovative technologies like the geko device, which stimulates blood flow in the lower leg, are helping reduce VTE risk when traditional methods aren’t suitable.

If you or a loved one is admitted to hospital, don’t be afraid to ask: ‘Have I been assessed for blood clots?”

Sue Bacon on the Importance of Addressing Hospital-Acquired DVT and PE

Stay updated with Hemostasis Today.

AIDS circulation support DVT Firstkind geko device Health Hematology Hemostasis Hemostasis Today Hospital-Acquired DVT Medicine PE Sue Bacon thrombosis VTE
NewsFeed